AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores new FDA-approved drugs for early-stage Alzheimer's patients, emphasizing their mechanism in removing beta amyloid plaques. It also addresses the high costs associated with these treatments and includes personal testimonials on their effectiveness.